Lakewood-Amedex Biotherapeutics annual operating margin
2024
2025
Lakewood-Amedex Biotherapeutics Operating Margin Growth & History (LABT)
Lakewood-Amedex Biotherapeutics's operating margin was −300.52% for fiscal 2025.
View full Lakewood-Amedex Biotherapeutics company overviewLakewood-Amedex Biotherapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −300.52% | −109.08 pp |
| 2024 | 2024-12-31 | −191.45% | — |
Lakewood-Amedex Biotherapeutics operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Lakewood-Amedex Biotherapeutics's operating margin decreased from −191.45% to −300.52%, a change of −109.08 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakewood-Amedex Biotherapeutics source filings ↗